These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 23531334)
1. Comparative absorption, distribution, and excretion of titanium dioxide and zinc oxide nanoparticles after repeated oral administration. Cho WS; Kang BC; Lee JK; Jeong J; Che JH; Seok SH Part Fibre Toxicol; 2013 Mar; 10():9. PubMed ID: 23531334 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics, tissue distribution, and excretion of zinc oxide nanoparticles. Baek M; Chung HE; Yu J; Lee JA; Kim TH; Oh JM; Lee WJ; Paek SM; Lee JK; Jeong J; Choy JH; Choi SJ Int J Nanomedicine; 2012; 7():3081-97. PubMed ID: 22811602 [TBL] [Abstract][Full Text] [Related]
3. Safety evaluation of sunscreen formulations containing titanium dioxide and zinc oxide nanoparticles in UVB sunburned skin: an in vitro and in vivo study. Monteiro-Riviere NA; Wiench K; Landsiedel R; Schulte S; Inman AO; Riviere JE Toxicol Sci; 2011 Sep; 123(1):264-80. PubMed ID: 21642632 [TBL] [Abstract][Full Text] [Related]
4. Quantitative biokinetics of titanium dioxide nanoparticles after oral application in rats: Part 2. Kreyling WG; Holzwarth U; Schleh C; Kozempel J; Wenk A; Haberl N; Hirn S; Schäffler M; Lipka J; Semmler-Behnke M; Gibson N Nanotoxicology; 2017 May; 11(4):443-453. PubMed ID: 28290734 [TBL] [Abstract][Full Text] [Related]
5. Toxicity of zinc oxide nanoparticles in rats treated by two different routes: single intravenous injection and single oral administration. Choi J; Kim H; Kim P; Jo E; Kim HM; Lee MY; Jin SM; Park K J Toxicol Environ Health A; 2015; 78(4):226-43. PubMed ID: 25674826 [TBL] [Abstract][Full Text] [Related]
6. A comprehensive toxicity study of zinc oxide nanoparticles versus their bulk in Wistar rats: Toxicity study of zinc oxide nanoparticles. Srivastav AK; Kumar M; Ansari NG; Jain AK; Shankar J; Arjaria N; Jagdale P; Singh D Hum Exp Toxicol; 2016 Dec; 35(12):1286-1304. PubMed ID: 26860690 [TBL] [Abstract][Full Text] [Related]
7. Optical imaging to trace near infrared fluorescent zinc oxide nanoparticles following oral exposure. Lee CM; Jeong HJ; Yun KN; Kim DW; Sohn MH; Lee JK; Jeong J; Lim ST Int J Nanomedicine; 2012; 7():3203-9. PubMed ID: 22811605 [TBL] [Abstract][Full Text] [Related]
8. Tissue distribution and elimination after oral and intravenous administration of different titanium dioxide nanoparticles in rats. Geraets L; Oomen AG; Krystek P; Jacobsen NR; Wallin H; Laurentie M; Verharen HW; Brandon EF; de Jong WH Part Fibre Toxicol; 2014 Jul; 11():30. PubMed ID: 24993397 [TBL] [Abstract][Full Text] [Related]
9. Tissue distribution and clearance of intravenously administered titanium dioxide (TiO2) nanoparticles. Shinohara N; Danno N; Ichinose T; Sasaki T; Fukui H; Honda K; Gamo M Nanotoxicology; 2014 Mar; 8(2):132-41. PubMed ID: 23272772 [TBL] [Abstract][Full Text] [Related]
10. Bioavailability of Silica, Titanium Dioxide, and Zinc Oxide Nanoparticles in Rats. Kim MK; Lee JA; Jo MR; Choi SJ J Nanosci Nanotechnol; 2016 Jun; 16(6):6580-6. PubMed ID: 27427756 [TBL] [Abstract][Full Text] [Related]
11. Long-term exposure to commercially available sunscreens containing nanoparticles of TiO2 and ZnO revealed no biological impact in a hairless mouse model. Osmond-McLeod MJ; Oytam Y; Rowe A; Sobhanmanesh F; Greenoak G; Kirby J; McInnes EF; McCall MJ Part Fibre Toxicol; 2016 Aug; 13(1):44. PubMed ID: 27534937 [TBL] [Abstract][Full Text] [Related]
12. Tissue distribution and excretion of intravenously administered titanium dioxide nanoparticles. Xie G; Wang C; Sun J; Zhong G Toxicol Lett; 2011 Aug; 205(1):55-61. PubMed ID: 21600967 [TBL] [Abstract][Full Text] [Related]
13. Bioavailability, distribution and clearance of tracheally-instilled and gavaged uncoated or silica-coated zinc oxide nanoparticles. Konduru NV; Murdaugh KM; Sotiriou GA; Donaghey TC; Demokritou P; Brain JD; Molina RM Part Fibre Toxicol; 2014 Sep; 11():44. PubMed ID: 25183210 [TBL] [Abstract][Full Text] [Related]
14. Dose-dependent clearance kinetics of intratracheally administered titanium dioxide nanoparticles in rat lung. Shinohara N; Oshima Y; Kobayashi T; Imatanaka N; Nakai M; Ichinose T; Sasaki T; Zhang G; Fukui H; Gamo M Toxicology; 2014 Nov; 325():1-11. PubMed ID: 25128818 [TBL] [Abstract][Full Text] [Related]
15. The in vitro absorption of microfine zinc oxide and titanium dioxide through porcine skin. Gamer AO; Leibold E; van Ravenzwaay B Toxicol In Vitro; 2006 Apr; 20(3):301-7. PubMed ID: 16182508 [TBL] [Abstract][Full Text] [Related]
16. Organ biodistribution, clearance, and genotoxicity of orally administered zinc oxide nanoparticles in mice. Li CH; Shen CC; Cheng YW; Huang SH; Wu CC; Kao CC; Liao JW; Kang JJ Nanotoxicology; 2012 Nov; 6(7):746-56. PubMed ID: 21950449 [TBL] [Abstract][Full Text] [Related]
18. Food-grade titanium dioxide (E171) and zinc oxide nanoparticles induce mitochondrial permeability and cardiac damage after oral exposure in rats. Correa Segura F; Macías Macías FI; Velázquez Delgado KA; Ramos-Godinez MDP; Ruiz-Ramírez A; Flores P; Huerta-García E; López-Marure R Nanotoxicology; 2024 Mar; 18(2):122-133. PubMed ID: 38436290 [TBL] [Abstract][Full Text] [Related]
19. Stratum corneum is an effective barrier to TiO2 and ZnO nanoparticle percutaneous absorption. Filipe P; Silva JN; Silva R; Cirne de Castro JL; Marques Gomes M; Alves LC; Santus R; Pinheiro T Skin Pharmacol Physiol; 2009; 22(5):266-75. PubMed ID: 19690452 [TBL] [Abstract][Full Text] [Related]
20. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat. Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]